This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
05/06/15 - 3:30:00 PM ET (BATS BZX Real-time Price)
Div Yield: --
ENTA Day's Range
ENTA 52 Week Range
ENTA Business Summary
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the infectious disease field in the United States.View ENTA key stats
Enanta Pharmaceuticals Inc - ENTA - EQUITY
Reviewed By: TheStreet Ratings on .
Report Summary: TheStreet Ratings team rates Enanta Pharmaceuticals Inc as a
Hold with a ratings score of C+.
Report Snippet: We rate ENANTA PHARMACEUTICALS INC (ENTA) a HOLD. The primary factors that have impacted our rating are mixed - some indicating strength, some showing weaknesses, with little evidence to justify the expectation of either a positive or negative performance for this stock relative to most other stocks. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures and notable return on equity. However, as a counter to these strengths, we find that the stock has had a generally disappointing performance in the past year.